State programme manager of Malaria Consortium, Okwulu Andrew, has disclosed that 40,678 confirmed Malaria cases in children ...

The first malaria treatment suitable for babies and very young children has been approved for use.It's expected to be rolled ...

The newly approved medication, Coartem Baby, is a combination of two antimalarials. It is a lower dose version of a tablet ...

The new drug, developed by Novartis and MMV, isn't a malaria vaccine, but can help treat babies with the disease.

The first-ever malaria medication designed specifically for babies and young children has received approval, with plans to ...

Coartem® (artemether-lumefantrine) Baby becomes first malaria treatment approved for newborn babies and young infants Rapid approvals in eight African countries now expected under a special global ...

Swiss medical authorities have approved the first drug suitable to treat malaria in babies and very young children. Eight ...

Novartis said on Tuesday it had received approval in Switzerland for Coartem Baby, which it said was the first drug to treat ...

The approval of the first malaria treatment for newborns and young infants could lead to imminent widespread use in Africa, ...

The State Programme Manager of Malaria Consortium, Okwulu Andrew, has disclosed that no fewer than 40,678 malaria cases were ...

The Kogi State Programme Manager of Malaria Consortium, Okwulu Andrew, has disclosed that in the year 2024, no fewer than 40,678 confirmed malaria cases in children under five years were ...

Novartis and a Swiss nonprofit have made history, scoring the world’s first approval for a medicine to treat babies who are ...